The global Biological Implants Market, valued at USD 25.71 Billion in 2022, is projected to expand significantly and reach USD 50.54 Billion by 2032, with a forecasted revenue compound annual growth rate (CAGR) of 7.8%. Key drivers of this market growth include an increase in the aging population, the prevalence of chronic illnesses, and advancements in implant materials and design.